These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32885767)

  • 1. Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art.
    Joshi G; Patel M; Chaudhary D; Sawant K
    Recent Pat Drug Deliv Formul; 2020; 14(3):201-213. PubMed ID: 32885767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
    Indoria S; Singh V; Hsieh MF
    Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
    Reis CP; Neufeld RJ; Ribeiro AJ; Veiga F
    Nanomedicine; 2006 Mar; 2(1):8-21. PubMed ID: 17292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.
    Morachis JM; Mahmoud EA; Almutairi A
    Pharmacol Rev; 2012 Jul; 64(3):505-19. PubMed ID: 22544864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA nanoparticles in drug delivery: the state of the art.
    Bala I; Hariharan S; Kumar MN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modification and local orientations of surface molecules in nanotherapeutics.
    Amin ML; Joo JY; Yi DK; An SS
    J Control Release; 2015 Jun; 207():131-42. PubMed ID: 25883030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-modified polymeric nanoparticles for drug delivery to cancer cells.
    Ahmed A; Sarwar S; Hu Y; Munir MU; Nisar MF; Ikram F; Asif A; Rahman SU; Chaudhry AA; Rehman IU
    Expert Opin Drug Deliv; 2021 Jan; 18(1):1-24. PubMed ID: 32905714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.
    Chiellini F; Piras AM; Errico C; Chiellini E
    Nanomedicine (Lond); 2008 Jun; 3(3):367-93. PubMed ID: 18510431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles.
    Nava-Arzaluz MG; Piñón-Segundo E; Ganem-Rondero A; Lechuga-Ballesteros D
    Recent Pat Drug Deliv Formul; 2012 Dec; 6(3):209-23. PubMed ID: 22734869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of Therapeutics.
    Batty CJ; Bachelder EM; Ainslie KM
    Trends Mol Med; 2021 Jun; 27(6):516-519. PubMed ID: 33903019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.